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Purpose: Numerous studies have been performed aimed at limiting the extent of retinal injury after ischemia, but there
is still no effective pharmacological treatment available. The aim of the present study was to examine the role of tumor
necrosis factor (TNF)α and its receptors (TNF-R1 and TNF-R2), especially considering the neuroretina and the retinal
vasculature since the retinal blood vessels are key organs in circulatory failure.
Methods: Retinal ischemia was induced in pigs by elevating the intraocular pressure to 80 mmHg in one eye, while the
other eye served as a control (sham-operated). One hour of ischemia was followed by 5 or 12 h of reperfusion. Retinal
circulation was examined in vivo by fundus imaging and fluorescein angiography. TNF-α levels were measured in the
vitreous using an angiogenesis antibody array test. The presence and amounts of TNF-α, TNF-R1, and TNF-R2 were
investigated in the neuroretina and in the retinal blood vessels, using immunofluorescence staining and real-time PCR
techniques.
Results: Fundus imaging showed obstructed blood flow when ischemia was induced, and reperfusion was clearly
visualized using fluorescein angiography. Ischemia resulted in elevated levels of TNF-α protein in the vitreous and TNF-
α mRNA in the neuroretina. TNF-α immunofluorescence staining was localized to the Müller cells and the outer plexiform
layer of the neuroretina. The expression of TNF-R1 and TNF-R2 mRNA was increased in both the neuroretina and retinal
arteries following ischemia-reperfusion. Immunofluorescence double staining for TNF-R1 and either smooth muscle actin
or 4',6-diamidino-2-phenylindole (DAPI) indicated expression in the cell membranes of the vascular smooth muscle cells.
Double staining with TNF-R1 and calbindin showed localization to the horizontal cells in the outer plexiform layer of the
neuroretina.
Conclusions: Retinal ischemia results in increased expression of TNF-α and its receptors (TNF-R1 and TNF-R2). Cellular
signaling pathways involving TNF may be important in the development of retinal injury following ischemia and thus an
interesting target for future development of pharmacological therapeutics.
Diabetes, vein thrombosis, and arterial occlusion are the
most common causes of retinal ischemia and a major cause of
sight-threatening  complications  and  blindness  [1].  It  is
important to limit the extent of the ischemic injury, for which
there is no successful pharmacological approach at present. If
more knowledge is gained of the effects of ischemia on the
retina  at  a  cellular  and  molecular  level,  pharmacological
targets may be revealed.
Retinal  ischemia  is  most  probably  multifactorial  and
probably has numerous overlapping signaling pathways that
may contribute to the injury. Tumor necrosis factor α (TNF-
α) is interesting in the context of retinal circulatory failure in
that it is involved in mediating the harmful processes that are
initiated following stroke [2-4] and ischemic heart disease
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[5,6]. Both TNF-α mRNA and protein expression have been
shown  to  be  increased  in  the  retina  following  ischemia
[7-10].  TNF-α  is  an  inflammatory  cytokine  and  has  been
suggested  to  stimulate  angiogenesis  following  ischemia
through the induced expression of many angiogenesis-related
genes [11-13]. It is known as a strong immunomediator and
pro-inflammatory cytokine, which is rapidly upregulated in
the brain after injury [4]. Furthermore, TNF-α is responsible
for some of the signaling events within cells that lead to
necrosis  or  apoptosis.  It  has  been  identified  as  a  highly
cytotoxic cytokine for tumor cells, causing tumor necrosis in
vivo and showing cytolytic activity against tumor cells in vitro
[14]. TNF-α can be both membrane bound and soluble in
tissues and its effects are mediated by the TNF receptors TNF-
R1 and TNF-R2 [15]. TNF-R1 can be fully activated by both
the membrane-bound and soluble forms of TNF-α, whereas
TNF-R2 only responds to the membrane-bound form. The
activation  of  TNF-R1  leads  to  the  activation  of  multiple
apoptotic pathways involving the activation of the pro-death
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2317Bcl-2 family of proteins, reactive oxygen species [16], and c-
jun NH2-terminal kinase [15]. These pathways are closely
interlinked  and  mainly  act  on  mitochondria,  resulting  in
apoptosis. TNF-α/TNF-R1 may simultaneously activate the
nuclear factor-κB (NF-κB) pathway, which can inhibit the
TNF-α-induced cell-death process [17]. In contrast, TNF-R2
may serve to potentiate the effects of TNF-R1 in promoting
cell death or inflammation [15,16]. Both TNF-R1 and TNF-
R2 have been shown to be increased in retinal ischemia in
mice where TNF-R1 increased neuronal death and TNF-R2
promoted neuroprotection [7]. The function and importance
of  the  TNF-α  system  in  retinal  circulatory  failure  hence
appears to be complex.
The aim of the present study was to examine the role of
TNF-α and its receptors in retinal ischemia-reperfusion injury
in detail, with regard to both the neuroretina and the retinal
vasculature, by using the porcine model of retinal ischemia-
reperfusion  induced  by  elevating  the  intraocular  pressure
(IOP) [18-20]. To achieve this, several methodologies were
used, including monitoring of the retinal vasculature in vivo
using  fundus  imaging  and  fluorescein  angiography.
Furthermore, TNF-α levels were measured in the vitreous
using  an  angiogenesis  antibody  array  test,  whereas  the
presence and levels of TNF-α, TNF-R1, and TNF-R2 were
investigated in both the neuroretina and in the retinal blood
vessels,  separately,  using  real-time  PCR  and
immunofluorescence staining techniques.
MATERIAL
Animals and anesthesia: A total of 15 healthy landrace pigs
(10 female and 5 male) with a mean bodyweight of 70 kg were
used for this study (conventional pig breeder, Lund, Sweden).
Before surgery the animals were fasted overnight with free
access  to  water.  An  intramuscular  injection  of  15  mg/kg
bodyweight  ketamine  (100  mg/ml  Ketaminol  vet™;
Farmaceutici  Gellini  S.p.A.,  Aprilia,  Italy)  was  used  in
combination with 2 mg/kg bodyweight xylazine (20 mg/ml
Rompun  vet™;  Bayer  AG,  Leverkusen,  Germany)  for
premedication. After induction of anesthesia with thiopental,
12.5  mg/kg  bodyweight  (Pentothal;  Abbott,  Stockholm,
Sweden),  the  animals  were  orally  intubated  with  cuffed
endotracheal tubes. Anesthesia was maintained by continuous
intravenous infusion of 20 mg/ml propofol (Diprivan™; Astra
Zeneca, Södertälje, Sweden), at a dosage of 0.1–0.2 mg/kg/
min, in combination with intermittent fentanyl administration
(Fentanyl B. Braun; B. Braun Malsungen AG, Melsungen,
Germany)  at  approximately  3.5  μg/kg/h.  Mechanical
ventilation  was  established  with  a  Siemens-Elema  900B
ventilator  (Siemens  Healthcare  Diagnostics,  Skärholmen,
Sweden)  in  the  volume-controlled  mode  and  adjusted  to
obtain  normocapnia.  The  animals  were  ventilated  with  a
mixture of oxygen (70%) and dinitrous oxide (30%). During
the procedure, the mean arterial blood pressure of the pigs was
92±7  mmHg.  After  completion  of  the  experiments,  the
animals were euthanized by a lethal injection of potassium, 2
mmol/kg (ADDEX potassium chloride; Fresenius KABI SE,
Uppsala, Sweden).
Ethics: All procedures and animal treatment took place in
accordance with the guidelines of the Ethics Committee of
Lund  University,  the  Institute  for  Laboratory  Animal
Research  (Guide  for  the  Care  and  Use  of  Laboratory
Animals), and the Association for Research in Vision and
Ophthalmology statement of Use of Animals in Ophthalmic
and Vision Research.
Retinal ischemia-reperfusion: The posterior chamber in one
eye was cannulated with a 30-gauge needle, and the IOP was
increased to 80 mmHg by continuous infusion of a balanced
salt  solution  for  ophthalmic  irrigation  (Content  per  ml:
0.48 mg CaCl2*2H2O, 0.75 mg KCl, 0.30 mg MgCl2*6H2O,
3.90  mg  Na-Acetate*3H2O,  1.70  mg  Na-Citrate*2H2O
6.40 mg NaCl, citric acid to adjust pH and water for injection;
AmoTM  EndosolTM;  AMO  Groningen  BV,  Groningen,  the
Netherlands). The IOP was verified using a Tono-Pen®XL
tonometer  (Medtronic,  Jacksonville,  FL).  The  other  eye
served as a control, and the same surgical procedure was
performed except for elevation of the IOP (this is referred to
as the “sham-operated” eye in the text and figures). After 1 h,
the cannulation needles were removed, and reperfusion of the
retinal vasculature was allowed to take place for 5 or 12 h
during  anesthesia.  Ischemia  was  confirmed  by  indirect
ophthalmoscopic  examination  and  fundus  imaging  as
described below.
Fundus imaging and fluorescein angiography: The pupils
were dilated with topical cyclopentolate hydrochloride (1%,
Cyclogyl; Alcon Laboratories Inc., Fort Worth, TX) to a pupil
diameter of 8–10 mm. The IOP was increased gradually from
the  normal  level  at10–20  to  40±5,  60±5,  70±5,  and
80±5 mmHg, and the fundus was imaged continuously at each
pressure level. Reperfusion was monitored using fluorescein
angiography.  Fluorescein  (5  ml,  100  mg/ml,  Fluorescite;
Alcon) was injected when the IOP was stable at 80 mmHg.
The IOP was then allowed to normalize, and the fundus was
imaged  during  pressure  normalization.  The  retinal
angiographic images were acquired with a RetCam 3 fundus
camera  (Clarity  Medical  Systems  Inc.,  Pleasanton,  CA).
Standard angiograms were recorded with a blue filter after the
injection of fluorescein dye. A wire ophthalmologic speculum
was required to separate the pigs’ eyelids for angiography.
Video images were recorded at a rate of 30 frames per second,
until full arteriovenous filling was observed.
Tissue preparation: After 5 or 12 h of reperfusion, both eyes
of each pig were enucleated under anesthesia (including the
optic nerve). The eyes were dissected, the anterior segment
was removed, and the vitreous humor collected. The vitreous
was homogenized by aspiration through a Pasteur pipette and
then centrifuged for 30 min at 16,000× g at 4 °C to precipitate
insoluble tissue. The vitreous homogenate was snap frozen in
liquid nitrogen and stored at −80 °C until further analysis.
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arteries and blood vessels of the eyes exposed to 5 h and 12 h
of ischemia-reperfusion were dissected in two different ways
and that the retina used for real-time PCR (see below) did not
consist of whole retinas but pieces. However, since both eyes
from a particular pig were dissected in the same way, it is
unlikely that the dissection technique would have affected the
results and conclusions drawn from the comparison of the
ischemia-reperfused  eye  and  the  control  eye  from  each
animal. Dissection was performed as follows: A slice along
the superior–inferior axis containing the optic nerve head of
the  eye  was  first  removed.  This  was  later  prepared  for
immunofluorescence  and  histological  investigation  (see
below). The retina was then dissected free from the sclera and
retinal  pigment  epithelium  in  the  remainder  of  the  eye.
Regarding the eyes exposed to 5 h of ischemia-reperfusion,
the large retinal arteries were isolated from the neuroretina by
careful dissection in a balanced salt solution for ophthalmic
irrigation at 4 °C. Pieces of each neuroretina and the retinal
arteries were frozen separately. Regarding the eyes exposed
to 12 h of ischemia-reperfusion, the neuroretina was isolated
by dissecting pieces lacking major blood vessels, in the same
balanced salt solution, at 4 °C and frozen as above. After
removing pieces of neuroretina, the rest of the retina was
placed in distilled water on ice for 1 h. During this time, the
tissue was gently and repeatedly aspirated through a Pasteur
pipette under magnification, taking care not to damage the
blood vessels. The blood vessels were collected and then
frozen. The neuroretina and retinal arteries or blood vessels
were collected, frozen, and stored at −80 °C until used for real-
time PCR experiments.
Histology:  Slices  from  both  eyes  were  fixed  in  4%
paraformaldehyde for 4 h. After fixation the tissue was rinsed
in 0.1 M Sørensen’s phosphate buffer (28 mM NaH2PO4 and
72 mM Na2HPO4; pH 7.4; Sigma-Aldrich, St. Louis, MO) and
then  washed  in  the  same  solution  with  increasing
concentrations of sucrose (10%–25%; Sigma-Aldrich). The
specimens  were  embedded  in  30%  egg  albumin  and  3%
gelatin  (Sigma-Aldrich)  and  were  stored  at  −80  °C  until
sectioning.  The  specimens  were  sectioned  at  12  µm  in  a
cryostat (Microm HM500M; Thermo Scientific, Walldorf,
Germany)  and  placed  on  microscope  slides  (Menzel,
Braunschweig, Germany), three sections on each slide. The
slides were allowed to dry at room temperature for 30–60 min
and were then stored at −20 °C until used.
Fluorescent immunohistochemistry: The slides were dried at
room temperature for 15 min and permeabilized in PBS (0.14
M NaCI, 0.01 M PO4 buffer, 0.003 M KCI, pH 7.45) plus
0.25% Triton X-100 (2×5 min). Blocking solution, containing
PBS+0.25% Triton X-100+1% BSA (BSA) and an additional
5% normal serum was added to the slides to avoid nonspecific
binding of antibodies. The slides were incubated for 1 h at
room temperature. Specimens were incubated overnight at
4 °C with the same blocking solution but with 2% normal
serum instead and the primary antibody of interest: 1:400
rabbit  polyclonal  TNF-R1  antibody  (ab19139;  Abcam
Biotechnology, Cambridge, UK), 1:400 goat polyclonal TNF-
α  (M-18)  antibody  (sc-1348;  Santa  Cruz  Biotechnology,
Heidelberg, Germany), 1:200 mouse monoclonal calbindin
antibody  (C9848;  Sigma-Aldrich,  St.  Louis,  MO),  and/or
1:200  mouse  monoclonal  anti-smooth  muscle  actin
(sc-53015; Santa Cruz Biotechnology).
The slides were rinsed in PBS (3×15 min), incubated in
blocking solution with the appropriate secondary antibody—
1:100  fluorescein  isothiocyanate  (FITC)  swine  antirabbit
(DakoCytomation,  Glostrup,  Denmark),  1:400  Alexa  488
donkey antigoat (Invitrogen, Carlsbad, CA), 1:300 Texas red
donkey antimouse (Jackson ImmunoResearch, West Grove,
PA)—and incubated at room temperature for 1 h. The slides
were  then  washed  in  PBS  (3×15  min)  and  mounted  in
antifading  mounting  medium  with  or  without  4´,6-
diamidino-2-phenylindole  (DAPI;  Vectashield;  Vector
Laboratories Inc., Burlingame, CA). Slides destined for use
with the primary antibody against TNF-α were placed in citric
acid (pH 6.0) in a microwave oven at full effect for 7 min
before the blocking step to open up the epitopes. Sections
incubated without primary or secondary antibody were used
as negative controls to verify the lack of autofluorescence and
nonspecific  secondary  antibody  staining.  The  staining
location was analyzed using a light microscope equipped for
fluorescence microscopy (Olympus BX60; Olympus, Tokyo,
Japan). Photographs were taken with a digital camera (Pixera
Pro  600ES;  Pixera,  Los  Gatos,  CA)  mounted  on  the
microscope.
RNA  extraction:  An  Allprep  DNA/RNA/Protein  Mini  Kit
(Qiagen, Valencia, CA) was used for the extraction of RNA.
Briefly, the tissue was homogenized in buffer RLT, including
β-mercaptoethanol, using a stainless steel bead and a Qiagen
TissueLyser. The stainless steel bead was removed and the
samples were centrifuged at 8,000× g. The supernatant was
then  transferred  to  an  Allprep  DNA  spin  column  and
centrifuged at 8,000× g. Ethanol (99.5%) was added to the
flow through, and the samples were transferred to an RNeasy
(Qiagen) spin column and centrifuged. On-column DNase
digestion  was  performed  according  to  the  manufacturer’s
instructions  (RNase-Free  DNase  Set,  50;  Qiagen).  The
column was washed with RW1 buffer, and RPE (Qiagen)
buffer, and the RNA was eluted in RNase-free water: 50 μl
for neuroretina specimens and 30 µl for the retinal arteries/
blood vessels. Following extraction, the RNA concentration
and purity was measured by the absorbance at 260 nm (A260/
A280 ratio) using a spectrophotometer (TECAN, Männedorf,
Switzerland). All samples were stored at -80 °C until further
analysis.
cDNA transcription and real-time PCR: Reverse transcription
of total RNA to cDNA was performed using the Taqman
GeneAmp RNA PCR kit (N808–0234; Applied Biosystems,
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(Applied Biosystems). cDNA was synthesized from 1 µg total
RNA in a 50-µl reaction with a master mix containing a
reverse  transcriptase  and  random  hexamers,  which  act  as
primers. The reaction was run at 25 °C for 10 min, 37 °C for
60 min, and 95 °C for 5 min. Following reverse transcription,
50  µl  double  distilled  H2O  was  added  to  neuroretina
specimens to a final volume of 100 µl, and all the cDNA
samples were stored at -80 °C. Real-time PCR was performed
in a GeneAmp 7300 Real Time PCR system, using the Gene
Amp Power SYBR® Green kit (Applied Biosystems). The
cDNA obtained as described above was used as a template in
a 25-µl reaction. A control without template was included in
all experiments. Forward and reverse primers were designed
using the Primer3 Input, version 0.4.0 [21] (Table 1). The
results  were  calculated  relative  to  the  amount  of  the
housekeeping genes β-actin (Actb) and elongation factor-1α
(EF-1α) since these are believed to be continuously expressed
at constant amounts in cells [22]. The primer sequences for
these housekeeping genes are given in Table 1.
The forward and reverse primers were dissolved in RNase
free water and a mixture of forward and reverse primers was
made. A master mix containing RNase-free water, Power
SYBR® Green (Applied Biosystems) and the chosen forward
and reverse primers (at a final concentration of 200 nM) was
added to the wells. One microliter cDNA from the specimens
containing  neuroretina  (sham-operated  or  ischemia-
reperfusion  eyes)  or  retinal  arteries/blood  vessels  (sham-
operated  or  ischemia-reperfusion  eyes)  was  added  to  the
wells. The real-time PCR reaction was performed with the
following profile: 1 cycle of 50 °C for 2 min and 95 °C for 10
min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1
min. This was followed by a dissociation step: 95 °C for 15 s,
60 °C for 30 s, and 95 °C for 15 s. One standard curve was
obtained for each pair of primers to confirm that the primers
were optimal and that the cDNA had been amplified with the
same efficiency during the real-time PCR process. The cycle
threshold (CT) can be expressed in terms of the amplification
efficiency (E), and the cDNA concentration:
CT = log (1 + E) −1log (concentration),
where the amplification efficiency has the optimal value of 1.
The amount of TNF-α, TNF-R1, and TNF-R2 mRNA in the
specimens was calculated relative to the amount of β-actin and
EF-1α mRNA in the same sample using the relation:
X0/R0 = 2CTR − CTX,
where X0=original amount of TNF-α, TNF-R1, or TNF-R2
mRNA; R0=original amount of Actb mRNA; CTR is the CT
value for β-actin; and CTX is the CT value for TNF-α, TNF-
R1, or TNF-R2.
Angiogenesis  antibody  array:  TNF-α  protein  levels  were
determined  in  vitreous  extracts  from  sham-operated  and
ischemia-reperfusion eyes following 12 h of reperfusion (n=6)
using  angiogenesis  antibody  array  membranes  (MA6310;
Panomics, Fremont, CA). The assay was performed according
to the according to the manufacturer’s instructions. In brief,
the  array  membranes  were  blocked  and  rinsed  before
incubation with vitreous extracts for 1 h at room temperature.
Membranes  were  subsequently  rinsed  and  incubated  with
Biotin-Conjugated  Anti-Cytokine/Anti-Angiogenesis  Mix
and then developed with Streptavidin-HRP Conjugate (both
supplied  in  the  kit).  Protein  spots  on  membranes  were
visualized using a Fujifilm LAS-1000 Luminescent Image
Analyzer (Fujifilm, Stamford, CT). The spot intensity was
quantified using Image J software [23].
Calculations and statistics: Statistical analysis was performed
using  the  paired  Student  ratio  t  test  with  the  Bonferroni
correction  for  multiple  comparisons.  Calculations  and
statistics were performed using GraphPad Prism 5.0 software
(GraphPad Software, Inc., La Jolla, CA). Differences were
considered significant when p<0.05. Results are presented as
means±the standard error of the mean.
Limitations:  The  pigs  in  this  study  were  anesthetized
throughout the study, and the interaction between ischemia
and  anesthesia  is  not  known  but  may  have  impacted  the
results. To limit the impact on the results and conclusions
drawn  from  the  study,  the  results  from  the  ischemia-
reperfusion eye were always compared with the results from
the sham-operated eye in the same animal. The other option
would be to wake the animals and re-anesthetize them again
after the reperfusion; this would, however, subject the animals
to increased stress, which is also known to induce metabolic
changes.  Taken  together,  we  believe  that  the  conclusions
drawn from the study have not been affected.
TABLE 1. REAL-TIME PCR PRIMERS. GENE NAME, GENBANK NUMBER AND PRIMER SEQUENCE FOR PRIMERS USED IN REAL-TIME PCR EXPERIMENTS.
Gene name GenBank number Forward primer sequence Reverse primer sequence
TNF-α EU682384 CCACCAACGTTTTCCTCACT TAGTCGGGCAGGTTGATCTC
TNF-R1 NM_213969 GCCACAAAGGCACCTACCTA GACATTTCACTCCGGCACTT
TNF-R2 EU116354 CACCAGGCTTCCGAATACAA ACGCAGAAACCGAGTTCCA
EF-1α AM040195 GCTGACTGTGCTGTCCTGATT TGTAGGCCAGAAGAGCATGCT
Actb U07786 CCTTCAACTCGATCATGAAGTGC CGTAGAGGTCCTTCCTGATGTCC
Gene name, GenBank number and primer sequence for primers used in real-time PCR experiments.
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could not be achieved for immunofluorescence with TNF-R2.
Our real-time PCR shows an effect of ischemia-reperfusion
on TNF-R2, and TNF-R2 has previously been suggested to be
neuroprotective [7]. This is a consequence of working with
the pig as an animal model since very few antibodies are
produced against pig proteins and none of the tested human/
rat/mouse  TNF-R2  antibodies  gave  reliable  and  clear-cut
results in our pig model.
RESULTS
Fundus imaging: The retinal blood vessels were visualized by
fundus imaging before the IOP was elevated and at increasing
levels of IOP. Before the IOP was elevated (normal pressure
of 10–20 mmHg), the pigs had a normal fundus with filled
blood vessels and venous pulsations were seen. When the
pressure was increased to 40 mmHg, the veins were slightly
less filled and there were no venous pulsations. At 60 mmHg,
blood perfusion was still maintained via both arteries and
veins,  although  these  blood  vessels  appeared  narrower.
Arterial pulsations could be observed, and the fundus was
paler. At a pressure of 70 mmHg, the blood vessels were thin
and the blood flow was slow and limited, with weak arterial
pulsations. At this pressure, the fundus was clearly pale. At
the  highest  IOP,  80  mmHg,  blood  flow  was  completely
obstructed. Boxcaring (break up of blood flow into clumps of
red blood cells giving an appearance of boxcars in the vessels)
phenomena  were  seen  in  both  veins  and  arteries,  and  a
retrograde flow was seen in superior arteries. Figure 1 shows
representative examples of fundus images at these different
pressure levels.
Fluorescein  angiography:  Fluorescein  angiography  was
performed at the highest IOP (80 mmHg) when no perfusion
of blood vessels could be seen. The IOP was then gradually
reduced and the following events were observed. First, there
was hyperfluorescence in the optic nerve head and filling of
the large blood vessel of the choroidal circulation. This was
followed by distinct pulsations and slight filling of the retinal
arteries. At this stage medium-sized choroidal vessels, but not
choriocapillaries,  were  perfused.  Blood  flow  through  the
arteries was then restored, but there was still no venous filling.
In the next stage, micro-emboli were seen to move slowly out
of the veins to allow reperfusion. See Figure 2 for fluorescein
angiography images.
Real-time PCR control experiments: Similar patterns of TNF-
α, TNF-R1, and TNF-R2 mRNA expression in the real-time
PCR  experiments  were  seen  in  the  neuroretina  for  pigs
subjected to 12 h of ischemia-reperfusion when using Actb
and EF-1α as reference genes. Examples of comparisons of
Actb and EF-1α as reference gene are as follows:
TNF-α  was  1.72±0.93  with  Actb  and  2.29±0.44  with
EF-1α as reference gene (p>0.3). TNF-R1 was 2.47±0.20 with
Actb and 2.34±0.29 with EF-1α as reference gene (p>0.3).
TNF-R2  was  1.19±0.20  with  Actb  and  1.07±0.14  with
EF-1α as reference gene (p=0.2171). The results suggest that
both Actb and EF-1α were trustworthy as references genes and
from here on the results in figures and text are given in relation
to Actb. The standard curves for each primer pair had similar
slopes: 3.3 for TNF-α, 3.4 for TNF-R1, 3.1 for TNF-R2, and
3.3 for Actb, indicating that they were amplified with similar
efficiency.
Tumor necrosis factor α after retinal ischemia-reperfusion:
TNF-α protein levels in the vitreous were higher in ischemia-
reperfusion eyes than in sham-operated eyes (Figure 3). TNF-
α mRNA levels were elevated in the neuroretina following
ischemia-reperfusion for 5 h but were not significantly altered
Figure 1. Fundus images from an eye subjected to successively
increasing intraocular pressure. At normal pressure (10–20 mmHg)
the pigs had a normal fundus with filled blood vessels. The filling of
the blood vessels decreased and the fundus became paler as the
intraocular pressure (IOP) increased. At an IOP of 80 mmHg, blood
flow  was  completely  inhibited.  IOP  is  given  with  ±5  mmHg
variability.
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2321after  12  h  of  reperfusion  (Figure  4).  TNF-α
immunofluorescence  staining  was  localized  to  the  Müller
cells, as judged by staining of the radial processes, and in the
outer plexiform layer (OPL) of the neuroretina (Figure 5).
Tumor necrosis factor receptor 1 and tumor necrosis factor
receptor 2 after retinal ischemia-reperfusion: TNF-R1 and
TNF-R2  mRNA  levels  were  generally  higher  in  the
neuroretina  and  retinal  blood  vessels  after  ischemia-
reperfusion than in sham-operated eyes (for detailed results
see  Figure  6).  TNF-R1  immunofluorescence  staining  was
primarily located in the cell membranes of the smooth muscle
cell layer of the blood vessels and was confirmed by triple
staining  for  TNF-R1,  smooth  muscle  actin,  and  4',6-
diamidino-2-phenylindole  (DAPI;  which  labels  the  cell
nuclei; Figure 7). Since TNF-R1 was primarily visualized in
the smooth muscle cell layer, it was more abundant in arteries
than veins. In the neuroretina, TNF-R1 staining was primarily
Figure 2. Fundus images during fluorescein angiography of a retina
that  is  exposed  to  high  intraocular  pressure  (80  mmHg).  A:  At
80 mmHg blood flow was completely obstructed. The intraocular
pressure (IOP) was then gradually reduced and the following events
were observed: (B) hyperfluorescence of the optic nerve head and
filling of the large blood vessel of the choroidal circulation; (C)
distinct pulsations and slight filling of the retinal arteries (at this
stage, medium-sized choroidal vessels, but not choriocapillaries,
were  perfused);  (D)  blood  flow  through  the  arteries  was  then
restored, but still no venous filling; (E) micro-emboli were seen to
move slowly out of the veins to allow reperfusion; (F) and finally,
background fluorescence after angiography.
observed  in  the  OPL.  Double  staining  with  TNF-R1  and
calbindin, a marker for horizontal cells [24], suggested TNF-
R1 expression in the latter cell type (Figure 8). Double staining
with TNF- α and TNF-R1 further showed co-localization of
the cytokine and its receptor in the OPL.
DISCUSSION
In the present study, the retinal vasculature was monitored in
vivo using fundus imaging and fluorescein angiography after
elevating the IOP to induce ischemia and lowering of the IOP
to allow reperfusion. Fundus imaging showed that the retinal
blood vessels were thinner than in normal eyes at an IOP of
60 mmHg, and at 80 mmHg there was no visible blood flow
through the retinal blood vessels. Fluorescein angiography
confirmed that there was no perfusion of retinal blood vessels
at an IOP of 80 mmHg, which is a pressure used in this and
other studies to create retinal ischemia [18-20]. La Cour et al.
[25] showed that the optic nerve oxygen tension remained
relatively constant for an IOP up to 40 cm H2O (29 mmHg),
but after the IOP was increased to 80 cm H2O (59 mmHg), the
optic nerve oxygen tension fell sharply, and further increases
in IOP above 120 cm H2O (88 mmHg) did not influence the
Figure 3. Tumor necrosis factor α in the vitreous. Extracts of vitreous
were incubated with an angiogenesis antibody array membrane and
tumor necrocsis factor α (TNF-α) protein levels in the vitreous in
eyes exposed to 12 h of ischemia-reperfusion (n=6), were compared
to sham-operated eyes (n=6). The graph shows the mean values
±standard error of the mean obtained from quantification of the spot
intensity and is expressed as the number of times by which the TNF-
α  increased  in  ischemia-reperfusion  compared  with  the  sham-
operated  eyes.  Statistical  analysis  was  performed  using  paired
Student ratio t test. Note that TNF-α protein levels in the vitreous
humor are higher following ischemia-reperfusion.
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2322oxygen tension of the optic nerve. This clearly indicates that
a pressure of 80 mmHg, which has been used in this and
previous  studies  [18-20],  is  sufficient  to  hinder  blood
perfusion of the retina. It furthermore fits well with other
studies that have verified that elevating IOP to 80 mmHg
results in ischemic injury to the retina, as shown by increased
number of terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) positive cells, pyknotic cell nuclei,
glial fibrillary acidic protein activation [19], and multifocal
electroretinogram  changes  [20].  However,  the  retina  is
relatively resistant to an ischemic insult compared to the brain,
which suffers widespread injury after only a few minutes of
cerebral  ischemia.  The  relative  resistance  of  the  retina  to
ischemia can be explained by local energy substrates that are
present in the vitreous and the retina and the ability to extract
ATP  (ATP)  in  the  absence  of  oxygen;  in  addition  the
edematous retina does not obstruct the microvasculature as
the thin retinal tissue has the vitreous cavity to expand into (in
contrast to the cranium that limits the brain) [1].
In  the  present  study,  retinal  reperfusion  following
ischemia was visualized with fluorescein angiography. There
is increasing evidence that reperfusion generates detrimental
intracellular  signaling  cascades  and  contributes  to
enlargement of the ischemic injury [1], and such reperfusion
Figure 4. Tumor necrosis factor α (TNFα) mRNA expression in the
neuroretina. TNF-α mRNA expression levels in the neuroretina of
sham-operated eyes were compared to eyes subjected to ischemia
followed by 5 h (n=4) and 12 h (n=8) of reperfusion (I-R), assessed
by real-time PCR. The mRNA levels were calculated relative to the
housekeeping gene Actb. Results are expressed as the number of
times by which the TNF-α mRNA increased in the neuroretina from
ischemia-reperfusion eyes compared with the sham-operated eyes
(mean±SEM).  Statistical  analysis  was  performed  using  paired
Student ratio t test with the Bonferroni correction.
injury may be the result of reactive hyperemia following the
Figure 5. Tumor necrosis factor α (TNF-α) immunofluorescence in
the neuroretina. TNF-α immunofluorescence staining was detected
in the outer plexiform layer and in the Müller cells of the neuroretina
in (A) a sham-operated eye and (B) the fellow eye subjected to
ischemia and 12 h of reperfusion. C-D: Enlargement showing TNF-
α staining in the (C) Müller cell processes (arrow heads) and (D)
cellbodies of the outer plexiform layer (arrow). E: Enlargement
showing double staining with TNF-α and calbindin (a horizontal cell
marker) and (F) TNF-α with its receptor TNF receptor 1 (TNF-R1).
DAPI was used to label the cell nuclei. The different images are from
separate sections of the retina. Abbreviations used in the figure are
outer nuclear layer (ONL), inner nuclear layer (INL), ganglion cell
layer (GCL), and outer plexiform layer (OPL).
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2323period of ischemia. For example, transient hyperemia, with an
increase in blood flow to almost twice the baseline (192%),
has been demonstrated in cerebral ischemia in rabbits [26].
Similarly, in a cat model of ischemia-reperfusion employing
a similar approach to that used here, retinal and choroidal
blood flows were nearly abolished during the ischemic insult
and the retinal blood flow was about twice the baseline level
after only 5 min of reperfusion [27]. It is believed that retinal
ischemia in combination with the ensuing reperfusion triggers
intracellular signaling cascades that lead to retinal injury [1].
TNF-α is one of many factors that may contribute to the
development of ischemic injury. TNF-α is known to affect the
growth, differentiation, survival, and physiologic function of
a variety of cells, including those in the immune system,
astrocytes, microglia, and smooth muscle cells [15]. In the
present  study,  TNF-α  protein  levels  were  elevated  in  the
vitreous following ischemia-reperfusion. The reason for this
cannot be deduced from the present study but may be related
to the increased expression of TNF-α in the neuroretina. TNF-
α has previously been shown to be increased in blood serum
from  mice  subjected  to  ischemia-reperfusion  [9]  and  in
Figure  6.  Tumor  necrosis  factor  (TNF)-R1  and  TNF-R2  mRNA
expression.  A-B:  TNF-R1  and  (C-D)  TNFR2  mRNA  expression
levels in (A, C) the neuroretina and (B, D) retinal blood vessels from
sham-operated eyes were compared to eyes subjected to ischemia
followed by 5 h (n=7) and 12 h (n=8) of reperfusion (I-R), assessed
by real-time PCR. The mRNA levels were calculated relative to the
housekeeping gene Actb. Results are expressed as the number of
times by which the TNFR1 and TNF-R2 mRNA increased in the
neuroretina  from  ischemia-reperfusion  eyes  compared  with  the
sham-operated  eyes  (mean±SEM).  Statistical  analysis  was
performed  using  paired  Student  ratio  t-test  with  the  Bonferroni
correction.
vitreous  [28]  and  blood  serum  [29]  from  patients  with
proliferative  diabetic  retinopathy.  The  present  results  also
show that the TNF-α mRNA level in the neuroretina was
significantly increased after ischemia and 5 h reperfusion,
while after 12 h of reperfusion no significant increase was
observed when compared to the sham-operated eyes. Similar
results have been seen in a mouse model of central retinal
artery occlusion, where TNF-α mRNA levels were increased
early but then almost reached control levels again after 7 days
[9]. Furthermore, an early increase in TNF-α mRNA has also
been  seen  in  a  rat  model  of  pressure-induced  ischemia-
reperfusion [8]. These results indicate that TNF-α is expressed
early after retinal ischemia-reperfusion injury and then returns
to  baseline  levels  again.  In  the  present  study  TNF-α
immunofluorescence was detected in the OPL and in glial
processes corresponding to Müller cells. This is in line with a
study from Fontaine et al. where staining of Müller processes
was shown in the neuroretina following ischemia-reperfusion
in mice [7].
TNF-α has been suggested to be an inducer of apoptotic
cell  death  via  TNF-R1  occupancy  in  a  caspase-mediated
Figure  7.  Retinal  artery  tumor  necrosis  factor  (TNF)-R1
immunofluorescence. Images show representative examples of TNF-
R1 immunofluorescence staining in an artery from (A) a sham-
operated eye and (B) the fellow eye subjected to ischemia and 12 h
of reperfusion. C-E: Enlargements show double staining for (C-E)
TNF-R1 and (E) the smooth muscle cell marker, smooth muscle actin
(SMA). It can be shown that TNF-R1 and SMA co-localize in the
smooth muscle cells in the blood vessels. D-E: Furthermore, staining
with DAPI (which labels the cell nuclei) showed that TNF-R1 was
located  in  the  cell  membrane  of  the  smooth  muscle  cells.  The
different images are from separate sections.
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2324pathway, which includes the activation of caspase-8 [30]. The
binding of TNF-α to TNF-R1 triggers a series of intracellular
events, resulting in the activation of two major transcription
factors, NF-κB and c-jun [31]. In a previous study by us using
Figure  8.  Tumor  necrosis  factor  (TNF)-R1  immunofluorescence
staining in the neuroretina. Representative examples of (A) a sham-
operated eye and (B) the fellow eye subjected to ischemia and 12 h
of reperfusion showing TNF-R1 staining in the outer plexiform layer
of  the  neuroretina.  C-H:  The  smaller  pictures  are  enlargements
showing double staining for (C-D) TNF-R1 and (E-F) calbindin
antibodies. Co-localization (G-H) could be seen in the horizontal
cells. G-H: DAPI showed staining of the nucleus. Asterisks indicate
labeled blood vessels. The original and enlarged images are from
separate sections. Abbreviations used in the figure are outer nuclear
layer (ONL), inner nuclear layer (INL), ganglion cell layer (GCL)
and outer plexiform layer (OPL).
the same model of retinal ischemia-reperfusion, c-jun mRNA
and  protein  levels  were  shown  to  be  increased  in  the
neuroretina [19]. Taken together, these results suggest that
TNF-α is increased in the vitreous and neuroretina during
ischemia-reperfusion  and  thus  becomes  involved  in  a
signaling cascade that may be detrimental to the retina.
In the present study, the expression of TNF-R1 and TNF-
R2 mRNA was increased in both the neuroretina and retinal
arteries following ischemia-reperfusion. Interestingly, TNF-
R1 and TNF-R2 mRNA levels have previously been shown to
be increased in the brain following ischemia [32,33], and
TNF-R1 mRNA levels have been shown to be increased in the
retina  in  patients  with  glaucoma  [10].  Such  observations
suggest  that  TNF-α  and  its  receptors  may  be  involved  in
causing ischemic damage in nervous tissue, which could occur
through a variety of pro-inflammatory effects, such as the
activation  of  microglia  and  astrocytes,  and  induction  of
intercellular  adhesion  molecule-1  [33,34].  Delayed
expression of intercellular adhesion molecule-1 in astrocytes
may  be  regulated  by  TNF-α  and  its  receptors  after  brain
ischemia [35]. TNF-R1 immunofluorescence was observed in
the OPL, which is in accordance with previous studies [7], and
showed co-localization with its activator TNF-α.
Inhibitors  of  TNF-α  are  now  being  constructed  and
include  a  soluble  TNF-α  receptor  antagonist  (etanercept),
three anti-TNF-α antibodies (adalimumab, infliximab, and
golimumab), and a humanized Fab fragment combined with
polyethylene  glycol  (certolizumab)  [36,37].  In  the  clinic,
TNF-α inhibitors are being used with success in the treatment
for  rheumatoid  arthritis,  psoriatic  arthritis,  and  Crohn’s
disease [36]. In light of this, modulating TNF expression in
the retina may be an interesting alternative for the treatment
of  retinal  injury  following  ischemia.  In  fact,  TNF-α
modulation has recently started to be considered in the context
of  refractory  diabetic  macular  edema  or  choroidal
neovascularization  secondary  to  age-related  macular
degeneration [38,39]. To further evaluate the importance of
TNF in retinal ischemia, the next step is to apply an inhibitor
of TNF to ischemic eyes and perform long-term studies to
follow the development of injury and to evaluate the effect of
blocking the TNF pathway.
In conclusion, ischemia was produced by increasing the
IOP to 80 mmHg. At this pressure blood flow to the retina was
obstructed,  as  shown  by  fundus  imaging.  After  1  h  of
ischemia, the IOP was allowed to return to normal levels and
the  retinal  vasculature  was  reperfused,  as  shown  by
fluorescein  angiography.  Retinal  ischemia-reperfusion
resulted in elevated levels of TNF-α protein in the vitreous
and TNF-α mRNA in the neuroretina; the expression of TNF-
R1  and  TNF-R2  mRNA  was  also  increased  in  both  the
neuroretina and retinal arteries. These results indicate that the
TNF signaling pathways may be interesting targets for the
development  of  pharmacological  therapeutics  aimed  at
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2325preventing  the  development  of  retinal  injury  following
ischemia.
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